Reduced MSCI offerings could slam SGX's FY2022 earnings: analyst

Uploaded By:  Nathanielle Punay Submitted By:  Nathanielle Punay Case Study:  No Futures movement may move to its rival in Hong Kong. Singapore Exchange has made a dent on its medium-term thesis after it announced that its license agreement for MSCI ex-Singapore products will expire in February 2021, where its impact to the bourse’s earnings may likely spill over to 2022, according to an analyst note by DBS Group Research. The report noted that Ex-MSCI Singapore products contributed 15% of equity derivatives contracts volume and 12% of total derivatives contracts volumes. read more